{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=shortened+fast&page=2", "query": { "intervention": "shortened fast", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=shortened+fast&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-29T16:05:55.530Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07202247", "title": "Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Prostate Carcinoma", "Recurrent Prostate Carcinoma" ], "interventions": [ { "name": "Antiandrogen Therapy", "type": "DRUG" }, { "name": "Behavioral Intervention", "type": "BEHAVIORAL" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Cardiac Computerized Tomographic Angiography", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Electronic Health Record Review", "type": "OTHER" }, { "name": "Internet-Based Intervention", "type": "OTHER" }, { "name": "Lifestyle Counseling", "type": "BEHAVIORAL" }, { "name": "Medical Device Usage and Evaluation", "type": "OTHER" }, { "name": "Nutritional Intervention", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Radiation Therapy", "type": "RADIATION" }, { "name": "Referral", "type": "OTHER" }, { "name": "Semaglutide", "type": "DRUG" }, { "name": "Short-Term Fasting", "type": "OTHER" }, { "name": "Tirzepatide", "type": "DRUG" } ], "intervention_types": [ "DRUG", "BEHAVIORAL", "PROCEDURE", "OTHER", "RADIATION" ], "sponsor": "City of Hope Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": "79 Years", "sex": "MALE", "summary": "30 Years to 79 Years · Male only" }, "enrollment_count": 60, "start_date": "2025-11-05", "completion_date": "2028-04-09", "has_results": false, "last_update_posted_date": "2026-08-17", "last_synced_at": "2026-09-29T16:05:55.530Z", "location_count": 1, "location_summary": "Duarte, California", "locations": [ { "city": "Duarte", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07202247" }, { "nct_id": "NCT00523627", "title": "Effects of Diet Changes on Metabolism", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Obesity" ], "interventions": [], "intervention_types": [], "sponsor": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 203, "start_date": "2008-05-22", "completion_date": null, "has_results": false, "last_update_posted_date": "2026-08-24", "last_synced_at": "2026-09-29T16:05:55.530Z", "location_count": 1, "location_summary": "Phoenix, Arizona", "locations": [ { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00523627" }, { "nct_id": "NCT03214380", "title": "A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "LY900014", "type": "DRUG" }, { "name": "Insulin Lispro", "type": "DRUG" }, { "name": "Insulin Glargine", "type": "DRUG" }, { "name": "Insulin Degludec", "type": "DRUG" }, { "name": "Metformin", "type": "DRUG" }, { "name": "SGLT2 inhibitor", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 933, "start_date": "2017-07-14", "completion_date": "2019-03-13", "has_results": true, "last_update_posted_date": "2020-03-27", "last_synced_at": "2026-09-29T16:05:55.530Z", "location_count": 32, "location_summary": "Fresno, California • La Mesa, California • Lancaster, California + 26 more", "locations": [ { "city": "Fresno", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "Lancaster", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Santa Clarita", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03214380" }, { "nct_id": "NCT03057119", "title": "Feasibility of SBIRT-PN", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Substance Use", "HIV/AIDS", "Older Adults", "Behavioral Intervention", "Infectious Disease" ], "interventions": [ { "name": "Psycho-educational content (5 Minutes)", "type": "BEHAVIORAL" }, { "name": "Readiness Assessment (10 minutes)", "type": "BEHAVIORAL" }, { "name": "Goal-Setting (5 minutes)", "type": "BEHAVIORAL" }, { "name": "Identifying and prioritizing needs (5 minutes)", "type": "BEHAVIORAL" }, { "name": "Explanation of Peer Navigator and Session wrap (5 minutes)", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Florida State University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 86, "start_date": "2018-02-12", "completion_date": "2022-03-31", "has_results": true, "last_update_posted_date": "2023-09-11", "last_synced_at": "2026-09-29T16:05:55.530Z", "location_count": 3, "location_summary": "Gainesville, Florida • Jacksonville, Florida • Lake City, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Lake City", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03057119" }, { "nct_id": "NCT06054607", "title": "Effect of Short-chain Fatty Acids on Aerobic Endurance", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Aerobic Endurance", "Metabolism" ], "interventions": [ { "name": "High-amylose maize starch+acetate/butyrate", "type": "DIETARY_SUPPLEMENT" }, { "name": "Low-amylose maize starch", "type": "OTHER" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "OTHER" ], "sponsor": "United States Army Research Institute of Environmental Medicine", "sponsor_class": "FED", "healthy_volunteers": true, "eligibility": { "minimum_age": "17 Years", "maximum_age": "39 Years", "sex": "ALL", "summary": "17 Years to 39 Years" }, "enrollment_count": 21, "start_date": "2023-07-21", "completion_date": "2025-05-01", "has_results": false, "last_update_posted_date": "2025-12-26", "last_synced_at": "2026-09-29T16:05:55.530Z", "location_count": 1, "location_summary": "Natick, Massachusetts", "locations": [ { "city": "Natick", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT06054607" }, { "nct_id": "NCT02120365", "title": "Rapid Determination Of The Clinical Utility Of Perampanel For The Treatment Of Alcohol Dependence", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Alcoholism" ], "interventions": [ { "name": "Perampanel", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Virginia Commonwealth University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "21 Years to 70 Years" }, "enrollment_count": 22, "start_date": "2019-06-01", "completion_date": "2022-02-16", "has_results": true, "last_update_posted_date": "2023-08-18", "last_synced_at": "2026-09-29T16:05:55.530Z", "location_count": 4, "location_summary": "Farmington, Connecticut • New Haven, Connecticut • West Haven, Connecticut + 1 more", "locations": [ { "city": "Farmington", "state": "Connecticut" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "West Haven", "state": "Connecticut" }, { "city": "Richmond", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02120365" }, { "nct_id": "NCT06644573", "title": "Evaluating the Efficacy and Safety of PROSOMNIA Sleep Therapy™ in Patients With Sleep Deprivation and Chronic Insomnia", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Chronic Insomnia", "Sleep Deprivation", "REM Behavior Disorder", "REM Sleep Behavior Disorder", "REM Sleep Measurement", "Insomnia", "Insomnia Related to Specified Disorder", "Insomnia Due to Other Mental Disorder", "Insomnia Comorbid to Psychiatric Disorder", "Insomnia Due to Anxiety and Fear", "Insomnia Related to Another Mental Condition", "Insomnia Disorders", "Idiopathic Hypersomnia", "Sleep Disorders, Circadian Rhythm", "Post Trauma Nightmares", "PTSD - Post Traumatic Stress Disorder", "Sleep Quality", "Anesthesia", "Anxiety", "Depression", "Mental Health", "Alzheimer Disease or Associated Disorder", "Parkinsons", "Circadian Rhythm", "Circadian Dysregulation", "PTSD", "Post-Traumatic", "Post-Traumatic Stress Disorder Complex", "Military Combat Stress Reaction", "Sleep", "Military Activity", "Veterans", "Shift Work Sleep Disorder", "Menopause Related Conditions", "Pain", "Cancer Pain", "Athletes" ], "interventions": [ { "name": "PROSOMNIA Sleep Therapy™ (PSTx)", "type": "PROCEDURE" }, { "name": "Anesthesia-Induced Sleep Therapy", "type": "PROCEDURE" }, { "name": "Diprivan (propofol), Astra-Zeneca", "type": "DRUG" }, { "name": "Continuous EEG Monitoring", "type": "DEVICE" } ], "intervention_types": [ "PROCEDURE", "DRUG", "DEVICE" ], "sponsor": "Nyree Penn", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 100, "start_date": "2025-11-01", "completion_date": "2026-05-01", "has_results": false, "last_update_posted_date": "2025-05-28", "last_synced_at": "2026-09-29T16:05:55.530Z", "location_count": 1, "location_summary": "Aventura, Florida", "locations": [ { "city": "Aventura", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06644573" }, { "nct_id": "NCT01848990", "title": "CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Type 1 Diabetes Mellitus" ], "interventions": [ { "name": "Commercial Hylenex® recombinant (hyaluronidase human injection)", "type": "DRUG" }, { "name": "Precommercial Hylenex recombinant (hyaluronidase human injection)", "type": "DRUG" }, { "name": "Insulin lispro", "type": "DRUG" }, { "name": "Insulin aspart", "type": "DRUG" }, { "name": "Insulin glulisine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Halozyme Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 456, "start_date": "2013-03", "completion_date": "2014-09", "has_results": true, "last_update_posted_date": "2018-11-07", "last_synced_at": "2026-09-29T16:05:55.530Z", "location_count": 39, "location_summary": "Concord, California • Encino, California • Escondido, California + 35 more", "locations": [ { "city": "Concord", "state": "California" }, { "city": "Encino", "state": "California" }, { "city": "Escondido", "state": "California" }, { "city": "Greenbrae", "state": "California" }, { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01848990" }, { "nct_id": "NCT03627546", "title": "HCV Seek, Test and Rapid Treatment for Young PWID", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hepatitis C", "Drug Use" ], "interventions": [ { "name": "Rapid Treatment strategy", "type": "OTHER" }, { "name": "Usual Care (facilitated referral)", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Weill Medical College of Cornell University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "29 Years", "sex": "ALL", "summary": "18 Years to 29 Years" }, "enrollment_count": 39, "start_date": "2018-09-18", "completion_date": "2021-06-30", "has_results": true, "last_update_posted_date": "2024-04-29", "last_synced_at": "2026-09-29T16:05:55.530Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03627546" }, { "nct_id": "NCT04538352", "title": "Transition From Basal/Bolus to Once-weekly Subcutaneous Semaglutide and Basal Insulin in Patients With T2D", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Type 2 Diabetes" ], "interventions": [ { "name": "Semaglutide", "type": "DRUG" }, { "name": "Insulin Degludec", "type": "DRUG" }, { "name": "Insulin aspart", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The Cleveland Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 60, "start_date": "2021-01-18", "completion_date": "2023-11-01", "has_results": true, "last_update_posted_date": "2025-02-18", "last_synced_at": "2026-09-29T16:05:55.530Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT04538352" } ] }